2026 US IPO report card: Which big listings soared and which flopped on debut?
The US IPO market has seen blockbuster debuts and disappointing listings in 2026, reflecting varying investor appetite across sectors. AI chipmaker Cerebras Systems led major offerings with an 89% opening gain, while several companies slipped belo...

The AI boom has fuelled record IPO fundraising this year, with several companies raising unprecedented sums through public offerings. However, concerns over rising AI expenditure, higher bond yields and expectations of interest rate hikes have slowed listing activity in the second half of the year, Reuters reported.
The Claude chatbot maker's debut marks the second multibillion-dollar IPO this year by a company valued at more than $1.5 trillion, following SpaceX's listing in June.
Read more: South Korean shares plunge over 4% to 10-month low as AI trade fears hit chipmakers
How the biggest IPOs of 2026 performed on debut
Among the largest listings of the year, AI chipmaker Cerebras Systems recorded the strongest opening, with its shares surging 89% above their $185 offer price in May after raising $5.55 billion.
Geothermal developer Fervo Energy opened 33.3% above its $27 offer price, while airflow-products maker Madison Air Solutions gained 18.5% after raising $2.23 billion.
Gas-engine manufacturer Innio debuted around 15% higher than its $27 offer price in June. South Korean chipmaker SK Hynix's US-listed shares opened 14% above their $149 offer price, following a $26.5 billion offering.
Honeywell-backed quantum computing company Quantinuum gained 13.3%, while SpaceX shares opened 11.1% above their $135 offer price after raising $75 billion. Milan-based technology company Bending Spoons recorded a more modest 7% premium.
Electrical-equipment maker Forgent Power Solutions was among the few major listings to disappoint, with shares opening 3.7% below their $27 offer price.
Top-performing IPO debuts of 2026
Drug developer Braveheart Bio was among the strongest performers, with shares opening around 67% above their $18 offer price in August. Weight-loss drugmaker Kailera Therapeutics followed with a 62.5% gain on its April debut.
Amazon-backed nuclear reactor developer X-Energy gained 30.9%, while space analytics firm HawkEye 360 and drugmaker ADARx Pharmaceuticals both recorded debut gains of around 30%.
Japanese payments app PayPay opened 19% above its offer price, while cryptocurrency custodian BitGo gained 24.6% on its January debut.
Worst-performing IPO debuts of 2026
On the other hand, several companies struggled to attract investor demand on their first trading day.
Swiss dental-technology company vVardis recorded the weakest debut among the listed offerings, with shares opening 22.2% below their $18 offer price in November.
Private equity-backed organic juice maker Suja Life fell 14.3% below its $21 offer price, while defence technology company Lyntris declined 11.4%.
KKR-backed ambulance operator GMR Solutions and nuclear fuel manufacturer Standard Nuclear both opened down 10%.
Restaurant chain Jersey Mike's shares opened 8.7% below their offer price, while Brazilian lender Agibank declined 8.3%. Data-centre provider Csquare had a largely flat debut, with shares opening around 0.5% below their $21 offer price.
The contrasting performances highlight the varying levels of investor appetite across sectors, even as the AI boom continues to drive large-scale public offerings. Anthropic's strong debut could signal market appetite for major AI listings ahead of OpenAI's expected IPO next year, Reuters reported.
(Disclaimer: This article is based on inputs from agencies. These do not represent the views of The Economic Times)
Download ET Markets APP